Reply: “Staging, Restaging and Treatment Response Assessment” in Lymphomas: What We Should Know.

Journal of Nuclear Medicine - China
doi 10.2967/jnumed.117.206946
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Society of Nuclear Medicine

Related search

What We Should Know About Natural Killer/T‐cell Lymphomas

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Atherosclerosis and Lupus: What We Know and What We Should Know

Journal of Rheumatology
RheumatologyAllergyImmunology
2009English

A Review of Recent Data in the Treatment of Gallbladder Cancer: What We Know, What We Do, and What Should Be Done

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Medicine
2014English

Besnoitiosis in Caribou: What We Know and What We Don't Know

Rangifer
2011English

What Should We Know to Develop an Information Robot?

PeerJ Computer Science
Computer Science
2015English

What We Know, What We Don't Know, and What We Need to Know About Welfare Reform

English

The Origin of Life: What We Know, What We Can Know and What We Will Never Know

Open Biology
BiochemistryImmunologyGeneticsMolecular BiologyNeuroscience
2013English

Quasicrystals. What Do We Know – What Can We Know?

Acta Crystallographica Section A: Foundations and Advances
Materials ScienceCondensed Matter PhysicsTheoretical ChemistryBiochemistryStructural BiologyInorganic ChemistryPhysical
2017English

What We Think and What We Know

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy